"Imvax secures $29m to support Phase IIb glioblastoma therapy trial" was originally created and published by Clinical Trials ...

Cecile Richards, a prominent advocate for women's rights and other progressive causes and former President of Planned ...

Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ:SHPH), a micro-cap pharmaceutical company with a market capitalization of $3.12 million, has amended its agreement with contract research organization ...

Despite being one of the most recognizable people in the world, Taylor Swift still made sure to humbly introduce herself to a ...

9, 2024 — Researchers used lab-grown organoids created from tumors of individuals with glioblastoma (GBM) to accurately model a patient's response to CAR T ... Molecular Zip Code Draws Killer T ...

The discovery of a new type of stem cell in the brain could usher in better treatments for the deadliest brain tumor.

Cecile Richards, the longtime advocate for women’s rights who was president of Planned Parenthood, has died. She was 67.

The Phase 2 trial design is to initially randomize 40 patients into two different dose levels, with 20 patients receiving 1,200 mg/day and 20 patients receiving 960 mg/day, to determine an optimal ...

LINDA M. LIAU NEUROSURGERY Chair, Department of Neurosurgery at UCLA Health; Professor and Director, UCLA Brain Tumor Center; ...

Shuttle Pharmaceuticals (SHPH) announced that it has achieved 25% enrollment in the initial randomized portion of its Phase 2 Clinical Trial of ...